$MDT OPTIONS TRADERS BET BIG ON MEDTRONIC GAINS. =====TARGET PRICE $115-$118=======. Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland. Longby Bullishcharts8
Medtronic broke all time highsWith the market down today, MDT doesn't care... It's breaking tested, heavy resistance at all time highs. Technicals look great as well. *Check chart for more info* Longby dorfmanmaster2
Fast Fall CorrectedWe got a retracement of the fall at the opening of the day and the capital that has flown in seemes to have been speculative. It is leaving now ahead of the end of the day.Shortby motleifaul0
A Technical Analysis for a loved one May 7 2019Good Morning, as we can see NYSE:MDT is in an uptrend and an ascending channel since December 2009, as long as this trend is not broken i would not worry and i will keep my position, the growth has been stable and it looks like a very solid company, the price it is above all its MA, i would only worry if the prices comes lower than USD80. Longby leoamartinez1
Is this stock worth owning?Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation product; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; hardware instruments and mesh fixation device; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, colorectal surgeons, urogynecologists, interventional radiologists, and ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and therapy management software. The company was founded in 1949 and is headquartered in Dublin, Ireland.by Skinwah5
Possible Inverse H&S Pattern in $MDTLast week may have been the shakeout before higher. Would give a little room on the downside but R/R looks good here for a long.Longby Sanzarific0
MDT. A good stock to buy and hold for the next 5-7 years?Everything is as usual, buy near uptrend. The company looks quite good, both from the point of view of fundamentals and technical analysis. I got in @ $88 and planning to hold this stock for the next 5 years or even more. In case of a reccesion or some other negative news, I'm looking to buy more @ $60-70.Longby Heist_FlyZ1
$MDT ON A ROLL!POSSIBLE REVERSAL.WITH EARNINGS COMING ON NOVEBER$MDT has been reaching higher high after higher. today it finally had massive pullback. This the best time to get for the cheapest price for when earnings come. Longby IvanderGodUpdated 2
Cardiac Swing- By insider Chairman & CEO of Medtronic Plc (MDT) Omar Ishrak bought 12,000 shares of MDT on 01/09/2019 at an average price of $84.05 a share. The total cost of this purchase was $1 million. I'm long from $82.61. Follow the $. Set stops.Longby UnknownUnicorn2993086Updated 2
Medtronic Breaking Out - 3 Uptrends in PlayBeen monitoring $MDT for a breakout partially due to their Minimed 670g being such a leap in insulin pump tech. Strong sales and should dominate competition until their tech catches up. Entry at daily REBZ $89.72. Trends: Year 6 of 12 Week 4 of 9 Day 2 of 9 Quarterly needs 2 mo without touching the mode to confirm a 12 bar signal.Longby Bloobers2
MDT Detected possible FDA approval!!!MDT: medtronic inc 2018-07-31 06:15:36 Detected possible FDA approvalLongby RocketTickers3
$MDT possible C&H with bullish momentum closing candle$MDT possible C&H with bullish momentum closing candleLongby jamesschwab3
MDT Detected possible FDA approval!!!MDT: medtronic inc 2018-06-15 08:30:31 Detected possible FDA approval Longby RocketTickers1
MDT05/29: Short - Tweetzer formed at previous swing high. - Bearish Divergence: RSI and MACD - Stoch crossed down at range boundary region - Tempted to test gap around 50%-62.8% Shortby SharpCharts1
MDT Bullish GartleyBullish Gartley... Price broke through the potential reversal zone, but it looks like we had a hard stop on the downside indicated by the three "almost doji candles". We are also seeing some momentum shift as indicated by the volume weighted MACD. Overall, we could see a little price pop tomorrow and purchasing some March calls would be a perfect play. Measurments - .786XA - 1.618BC - AB=CDLongby jlb17ww2225
MDT Detected possible FDA approval this morning!!!MDT: medtronic inc 2018-02-26 08:00:52 Detected possible FDA approvalLongby RocketTickers1
#MDT #stock #shortMDT has formed an H&S on the hourly chart. Indicators are looking down and so is the trend. Trend is negative all the way up to the daily.Shortby The_Patterns_Guy2